Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$168M |
| 2 |
AbbVie
ABBV
|
+$164M |
| 3 |
TSMC
TSM
|
+$147M |
| 4 |
Amgen
AMGN
|
+$139M |
| 5 |
Walmart Inc
WMT
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$186M |
| 2 |
AGN
Allergan Inc
AGN
|
+$175M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$175M |
| 4 |
HCBK
HUDSON CITY BANCORP INC
HCBK
|
+$172M |
| 5 |
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 17.16% |
| 3 | Financials | 12.6% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KATE
1551
DELISTED
Kate Spade & Company
KATE
| $731K | ﹤0.01% |
21,900
-23,400
| -52% | -$741K |
|
|
ATHN
1552
DELISTED
Athenahealth, Inc.
ATHN
| $730K | ﹤0.01% |
6,117
-1,700
| -22% | -$227K |
|
|
AAWW
1553
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $730K | ﹤0.01% |
+16,977
| New | +$792K |
|
1554
AMN Healthcare
AMN
$1.3B
| $725K | ﹤0.01% |
31,443
+17,300
| +122% | +$358K |
|
1555
Omeros
OMER
$1.4B
| $725K | ﹤0.01% |
32,900
-9,800
| -23% | -$224K |
|
|
TBI
1556
Trueblue
TBI
$325M
| $721K | ﹤0.01% |
29,645
-86,205
| -74% | -$1.94M |
|
|
CBL
1557
DELISTED
CBL& Associates Properties, Inc.
CBL
| $719K | ﹤0.01% |
36,300
+16,900
| +87% | +$340K |
|
|
SRCI
1558
DELISTED
SRC Energy Inc
SRCI
| $719K | ﹤0.01% |
60,693
-7,169
| -11% | -$84.9K |
|
1559
Neogen
NEOG
$2.52B
| $715K | ﹤0.01% |
40,787
+23,854
| +141% | +$437K |
|
1560
SLM Corp
SLM
$4.97B
| $715K | ﹤0.01% |
77,100
-1,324,447
| -94% | -$12.4M |
|
|
TMH
1561
DELISTED
Team Health Holdings Inc
TMH
| $714K | ﹤0.01% |
12,200
+8,600
| +239% | +$488K |
|
|
RPRX
1562
DELISTED
Repros Therapeutics Inc.
RPRX
| $713K | ﹤0.01% |
82,900
+58,700
| +243% | +$525K |
|
|
MRC
1563
DELISTED
MRC Global
MRC
| $712K | ﹤0.01% |
60,043
-137,571
| -70% | -$1.72M |
|
|
PX
1564
DELISTED
Praxair Inc
PX
| $711K | ﹤0.01% |
5,889
+1,800
| +44% | +$225K |
|
|
KNL
1565
DELISTED
Knoll, Inc.
KNL
| $711K | ﹤0.01% |
+30,329
| New | +$631K |
|
|
TUES
1566
DELISTED
Tuesday Morning Corp
TUES
| $710K | ﹤0.01% |
44,088
-4,534
| -9% | -$85.6K |
|
1567
Pricesmart
PSMT
$5.4B
| $707K | ﹤0.01% |
8,317
-2,200
| -21% | -$182K |
|
|
DXM
1568
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
| $707K | ﹤0.01% |
168,906
-4,600
| -3% | -$30.9K |
|
|
MCRL
1569
DELISTED
MICREL INC
MCRL
| $706K | ﹤0.01% |
46,800
+11,600
| +33% | +$169K |
|
|
GREK
1570
Global X MSCI Greece ETF
GREK
$344M
| $704K | ﹤0.01% |
+21,284
| New | +$776K |
|
|
HOUS
1571
DELISTED
Anywhere Real Estate
HOUS
| $701K | ﹤0.01% |
15,400
+1,000
| +7% | +$46K |
|
1572
Lakeland Financial Corp
LKFN
$1.49B
| $700K | ﹤0.01% |
25,884
+8,100
| +46% | +$217K |
|
|
CAVM
1573
DELISTED
Cavium, Inc.
CAVM
| $697K | ﹤0.01% |
+9,837
| New | +$639K |
|
|
LO
1574
DELISTED
LORILLARD INC COM STK
LO
| $695K | ﹤0.01% |
10,629
-2,338,972
| -100% | -$156M |
|
1575
Ecolab
ECL
$80.7B
| $694K | ﹤0.01% |
6,065
-13,100
| -68% | -$1.44M |
|
Similar funds
Cliff Asness's Q1 2015 Portfolio in Review
As of Q1 2015, Cliff Asness held 2,617 positions worth $43.8B, down 8.4% from $47.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Cliff Asness withdrew a net $2.6B in Q1 2015, closing 480 positions and reducing 931 holdings. Its most notable exit was Allergan Inc, an estimated $175M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Cliff Asness opened a new position in Qorvo worth $68.6M.
- Cliff Asness's largest Q1 2015 buy was Qorvo: 860,877 shares worth $68.6M.
- Cliff Asness added most to Microsoft in Q1 2015, an estimated $168M increase.
- Cliff Asness's biggest Q1 2015 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $186M.
- Cliff Asness fully exited Allergan Inc in Q1 2015, selling an estimated $175M.
- Cliff Asness's ten largest holdings make up 11% of its $43.8B portfolio in Q1 2015.
- Cliff Asness opened 198 new positions and closed 480 in Q1 2015.
- Cliff Asness's portfolio value fell 8.4% quarter-over-quarter to $43.8B.
Based on AQR Capital Management's 13F filing for Q1 2015, filed 15 May 2015.